# FDA recall D-1094-2023

> **Imprimis NJOF, LLC** · Class III · drug recall initiated 2023-08-10.

## Product

Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.

## Reason for recall

Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-1094-2023
- **Recalling firm:** Imprimis NJOF, LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-08-10
- **Report date:** 2023-08-30
- **Termination date:** 2024-01-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ledgewood, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1094-2023

## Citation

> AI Analytics. FDA recall D-1094-2023. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1094-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*